Natraceutical Group


	FINANCIAL INFORMATION
	Annual Report
	Quartely Results
	RELEVANT FACTS
	CORPORATE GOVERNANCE
	Corporate Governance Report
	Board of Directors
	Board Committees
	Regulation of the Board of Directors
	Regulation of the General Shareholders´ Meeting
	Internal Code of Conduct
	Shareholders´ Agreements
	GENERAL INFORMATION
	Company´s Profile
	Corporate By-laws
	Treasury Stock
	Quoted Subsidiaries
	Issues
	Dividends
	Shareholders
	Analysts reports on the company
	SHAREHOLDERS GENERAL MEETING
	DIRECT LINE

		09/03/2011 Final decision on the call option on Natraceutical Final decision on the call option granted by Natraceutical’s parent company Natra SA, to the Brazilian company Bio Group Brazil, about a potential acquisition of a majority stake in Natraceutical SA. (87,44 Kb)

		23/11/2010 Resignation to the Board of Directors of Naturex The company informed about its resignation as member of the Board of Directors of Naturex (72,04 Kb)

		10/11/2010 Call option granted to BGB Starting date for the call option granted by the principal shareholder, Natra to the Brazilian company Bio Group Brazil, about his potential stake in Natraceutical (73,74 Kb)

		07/10/2010 Strategic agreement with BGB Strategic agreement with the Brazilian company Bio Group Brazil (107,67 Kb)

		15/04/2010 Refinancing Update on refinancing process (40,87 Kb)

		04/01/2010 Execution of fusion with Naturex Natraceutical Group and Naturex run the integration of Natraceutical Ingredients Division into Naturex . (179,75 Kb)

		10/12/2009 Update on the progress of the merge with Naturex The company informs about the progress regarding the conditions precedent for the integration of Natraceutical's Ingredients Division into Naturex. (183,37 Kb)

		03/11/2009 Starting the refinancing process Start the negotiation process with the main creditor banks to refinance the company debt and carry out its restructuring process. (122,64 Kb)